sexta-feira, 16 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleCrunchbase News

Crunchbase Data Shows AI’s Most Active Startups Are Becoming Serial Acquirers

View original at news.crunchbase.com
Crunchbase News - Funding Ma Title: Crunchbase Data Shows AI’s Most Active Startups Are Becoming Serial Acquirers Date: 2026-10-06 11:00 Source: https://news.crunchbase.com/ma/ai-startup-acquisitions-legal-healthcare-openai/ <p>Some of the AI industry’s fastest-growing startups are becoming serial acquirers, buying sma…
Opening lines of the source · Crunchbase News · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Harvey's M&A strategy is selective but aggressive; it holds a high talent bar, moves quickly on additive companies and will continue to do so this year and beyond

    60% confidence
  • M&A is explicitly part of how Legora accelerates what it is building, judged by whether a deal gets it somewhere faster than it could alone

    60% confidence
  • Harvey's M&A strategy is rooted in finding technical talent with high ownership and deep experience in legal tech or an adjacent space

    60% confidence
  • Prices were disclosed for only 12 of the 195 deals, making overall spending difficult to gauge

    60% confidence
  • Speed drives AI M&A; acquiring is faster than building, growth investors want 10x growth, and high valuations give startups cheap stock currency for low-dilution deals

    60% confidence
  • TakeOff was posting a near 8-figure run rate with a team of three; Sierra's acquisition offered a way to accelerate and build at greater scale

    60% confidence
  • Acquisitions of AI startups by other venture-backed AI companies reached 195 through Sept. 29, 14% more than in all of 2025, while the number of buyers grew just 2%

    60% confidence
  • At the current pace, even more AI startup M&A should be expected in the months and years ahead

    60% confidence
  • 67 repeat buyers accounted for about 42% of all tracked transactions across the three-year period

    60% confidence

Citado nestas reportagens da Via News

O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,378 documentos-fonte arquivados
Consulte estes dados → isubstrate.com